Skip to content
★ Sign in to follow
SS

Sanjay Shrivastava

Board Director
Director
enVVeno Medical Corp
Insider activity · 24 months1 buy0 salesCumulative net flow
Total declarations
5
Company
1
▲ Purchases (2 ops.)
€19k
▼ Sales (0 ops.)
—

Latest filing published 26 Dec 2024 for enVVeno Medical Corp, €15k.

Filing timeline

BuySale
Sanjay Shrivastava

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

Closed purchases

Market purchases
2
Positive at T+90
50%
Median T+90
+21.2%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 26 Dec 2024 · 683 days ago · €15k
    -89.5%
    Entry US$110.25 · Close at T+365 US$11.59
  • Filed 01 Jul 2022 · 1592 days ago · €3,674
    -21.3%
    Entry US$144.02 · Close at T+365 US$113.40

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Sanjay Shrivastava: trading record in brief

Sanjay Shrivastava (board member) discloses dealings in enVVeno Medical Corp to SEC (Form 4). Between 27 November 2018 and 24 December 2024, the trades on record add up to 5 filings.

No open-market sale appears; the market trades are 2 purchases worth €19k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 2 share grants and 1 option exercise. Since January 2024: 1 purchase and no sales on the market.

The latest filing, published on 26 December 2024, reports an open-market purchase of €15k in enVVeno Medical Corp. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Sanjay Shrivastava

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations5 total

5 of 5 declarations